Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Clinical Comparison of the Endeavor [zotarolimus] and the Cypher [sirolimus] Coronary Stents in Non-Selected Angina Pectoris Patients

Trial Profile

Randomized Clinical Comparison of the Endeavor [zotarolimus] and the Cypher [sirolimus] Coronary Stents in Non-Selected Angina Pectoris Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2018

At a glance

  • Drugs Sirolimus (Primary) ; Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Registrational; Therapeutic Use
  • Acronyms SORT-OUT-III
  • Most Recent Events

    • 31 Oct 2018 The SORT OUT III 10-year results will be reported at the ESC Congress. The subgroup analysis assessing 10 year outcomes in patients with or without diabeties has not yet been analyzed but will be ready for presentation at TCT as per trial design presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
    • 25 Sep 2018 Trial design presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
    • 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top